SCHEMBL8872031

SCHEMBL8872031

O=c1[nH]c2ccc(Cl)c(Cl)c2c(=O)o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
F2 P00734 1/20 0.43
CFD P00746 1/20 0.43
KMO O15229 1/20 0.43
NOS1 P29475 4/20 0.41
NOS2 P35228 3/20 0.41
NOS3 P29474 2/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
ADRA2A P08913 1/20 0.41
TSHR P16473 1/20 0.41
THPO P40225 1/20 0.41
BLM P54132 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27474463 0.82 NOS1 (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3576862 0.82 NOS1 (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL27248981 0.78 AR (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL147448 0.78 F2 (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2782854 0.77 F2 (0.37) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL27701688 0.72 F2 (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL10756217 0.70 F2 (0.43) F2CFDKMONOS1NOS2
SCHEMBL2062117 0.70 F2 (0.43) F2CFDKMONOS1NOS2
SCHEMBL4492747 0.70 NOS1 (0.44) F2CFDNOS1NOS2NOS3
SCHEMBL8573976 0.70 CYP1A2 (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597922-A Glycine receptor antagonist pharmacophore STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) 1997-01-28 US disclosed
WO-1996004288-A1 GLYCINE RECEPTOR ANTAGONIST PHARMACOPHORE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1996-02-15 WO disclosed
EP-0100906-B1 TRI- AND TETRACYCLIC IMIDAZO(1,5-A)(1,4)BENZODIAZEPIN-1-CARBOXYLIC-ACID DERIVATIVES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-05-13 EP disclosed
US-4489003-A ANTICONVULSANTS, TRANQUILLIZERS HOFFMANN-LA ROCHE INC. (US) 1984-12-18 US disclosed
EP-0100906-A2 Tri- and tetracyclic imidazo(1,5-a)(1,4)benzodiazepin-1-carboxylic-acid derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-02-22 EP disclosed
EP-0057424-A1 Process for the preparation of anthranilic acid amides BASF Aktiengesellschaft (DE) 1982-08-11 EP disclosed
EP-0002624-B1 2-BENZAZEPINE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITHKLINE BECKMAN CORPORATION (US) 1981-10-14 EP disclosed
EP-0002624-A1 2-Benzazepine compounds, processes for their preparation and pharmaceutical compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1979-06-27 EP disclosed